| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2898526 | Cardiology Clinics | 2007 | 8 Pages |
Abstract
Activation of the renin-angiotensin system (RAS) plays an important role in the pathogenesis of heart failure. Thus, strategies for the treatment of heart failure have focused on agents that block the RAS. More recently, the role of angiotensin receptor blockers (ARBs) in heart failure therapy has been better defined. This article examines the rationale and role of ARBs in the treatment of patients with heart failure on the basis of evidence from clinical trials.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kumudha MD, Douglas L. MD, Anita MD, MPH,